Lv1
30 积分 2023-02-13 加入
Discovery of efficacy biomarkers for non-small cell lung cancer with first-line anti-PD-1 immunotherapy by
data-independent acquisition mass spectrometry
2年前
已完结
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
2年前
已完结
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
2年前
已完结
Clinicopathologic and genomic factors impacting efficacy of first-line chemoimmunotherapy in advanced non-small cell lung cancer (NSCLC)
2年前
已完结
Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer
2年前
已完结
Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives
2年前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
2年前
已完结
皖公网安备34019202002308
